Boaquina, Jacky Lyn B.
HRN: 24-31-95 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/04/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/04/2024
01/11/2024
IV
2.25g
Q6hrs
Septic Shock 2 Infected Breast Mass
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes